Preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in patients with open-angle glaucoma and ocular hypertension: results of an open-label observational study

Documenti analoghi

• A 6-Month Study Comparing Efficacy, Safety, and Tolerability of the Preservative-free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% versus Each of Its Individual Preservative-Free Components
  di: Pfeiffer, Norbert, et al.
  Pubblicazione: (2014)
• Fixed-Dose Combination of Tafluprost and Timolol in the Treatment of Open-Angle Glaucoma and Ocular Hypertension: Comparison with Other Fixed-Combination Products
  di: Holló, Gábor, et al.
  Pubblicazione: (2014)
• Prospective Observational Post-marketing Study of Tafluprost 0.0015%/Timolol 0.5% Combination Ophthalmic Solution for Glaucoma and Ocular Hypertension: Short-Term Efficacy and Safety
  di: Takagi, Yasutaka, et al.
  Pubblicazione: (2016)
• Efficacy and tolerability of preservative-free tafluprost 0.0015% in Korean patients with glaucoma
  di: Hwang, Young Hoon
  Pubblicazione: (2014)
• Long term safety and tolerability of Tafluprost 0.0015% vs Timolol 0.1% preservative-free in ocular hypertensive and in primary open-angle glaucoma patients: a cross sectional study
  di: Rolle, Teresa, et al.
  Pubblicazione: (2017)